New Delhi: The Indian Council of Medical Research (ICMR) on Wednesday approved the self-use Rapid Antigen Test or RAT kit ‘CoviSelf’ for Covid-19 testing, that is developed by Indian company Mylab Discovery Solutions.
The self-use test can be used by symptomatic individuals and immediate contacts of confirmed cases, as per ICMR guidelines. Users of this test will not need sample collection by a healthcare professional and could test it at home, an official statement issued today has said. Advising against the indiscriminate use of the kits, ICMR has reiterated that all symptomatic individuals who test negative by RAT should get themselves immediately tested by RTPCR.
ICMR has reiterated that all symptomatic individuals who test negative by RAT should get themselves immediately tested by RTPCR. “This is especially important as RATs are likely to miss [a] few positive cases presenting with a low viral load,” the advisory states. ICMR stated that the home testing mobile app should be downloaded by all users and that data in the app will be centrally captured in a secure server connected with the ICMR Covid-19 testing portal.
“All users are advised to click a picture of the test strip after completing the test procedure with the same mobile phone used for downloading the mobile app and user registration,” ICMR has said.
The advisory stated that all RAT-negative symptomatic individuals may be treated as suspect Covid-19 cases and are advised to follow home isolation protocol while awaiting RTPCR test result.
“All individuals who test positive may be considered as true positives and no repeat testing is required. All test positive individuals are advised to follow home isolation and care as per ICMR & Ministry of Health & Family Welfare (MoH&FW) protocol,” it states.